The effects of 12 weeks of HMR 3339, a novel selective estrogen receptor modulator, on markers of coagulation and fibrinolysis: a randomized, placebo-controlled, double-blind, dose-ranging study in healthy postmenopausal women

T.E. Vogelvang, V. Mijatovic, P. Kenemans, J.J. Emeis, J.A. Heijst, M.J. van der Mooren

Research output: Contribution to journalArticleAcademicpeer-review

Original languageEnglish
Pages (from-to)1384-1394
JournalAmerican Journal of Obstetrics and Gynecology
Issue number4
Publication statusPublished - 2005

Cite this